A detailed history of Reuter James Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 18,384 shares of LLY stock, worth $13.7 Million. This represents 3.04% of its overall portfolio holdings.

Number of Shares
18,384
Previous 335 5387.76%
Holding current value
$13.7 Million
Previous $303,000 5275.25%
% of portfolio
3.04%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $13.9 Million - $17.3 Million
18,049 Added 5387.76%
18,384 $16.3 Million
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $724 - $909
1 Added 0.3%
335 $303,000
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $197,794 - $264,621
334 New
334 $259,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Reuter James Wealth Management, LLC Portfolio

Follow Reuter James Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reuter James Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reuter James Wealth Management, LLC with notifications on news.